• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

前列腺癌患者现代外照射放疗的继发癌症风险:分割和剂量分布的影响。

Secondary cancer risk from modern external-beam radiotherapy of prostate cancer patients: Impact of fractionation and dose distribution.

机构信息

Department of Diagnostic and Therapeutic Radiology, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok 10400, Thailand.

出版信息

J Radiat Res. 2021 Jul 10;62(4):707-717. doi: 10.1093/jrr/rrab038.

DOI:10.1093/jrr/rrab038
PMID:33993271
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8273793/
Abstract

Modern radiotherapy (RT) uses altered fractionation, long beam-on time and image-guided procedure. This study aimed to compare secondary cancer risk (SCR) associated with primary field, scatter/leakage radiations and image-guided procedure in prostate treatment using intensity-modulated RT (IMRT), CyberKnife stereotactic body RT (CK-SBRT) in relative to 3-dimensional conformal RT (3D-CRT). Prostate plans were generated for 3D-CRT, IMRT (39 fractions of 2 Gy), and CK-SBRT (five fractions of 7.25 Gy). Excess absolute risk (EAR) was calculated for organs in the primary field using Schneider's mechanistic model and concept of organ equivalent dose (OED) to account for dose inhomogeneity. Doses from image-guided procedure and scatter/leakage radiations were determined by phantom measurements. The results showed that hypofractionation relative to conventional fractionation yielded lower SCR for organs in primary field (p ≤ 0.0001). SCR was further modulated by dose-volume distribution. For organs near the field edge, like the rectum and pelvic bone, CK-SBRT plan rendered better risk profiles than IMRT and 3D-CRT because of the absence of volume peak in high dose region (relative risk [RR]: 0.65, 0.22, respectively, p ≤ 0.0004). CK-SBRT and IMRT generated more scatter/leakage and imaging doses than 3D-CRT (p ≤ 0.0002). But primary field was the major contributor to SCR. EAR estimates (risk contributions, primary field: scatter/leakage radiations: imaging procedure) were 7.1 excess cases per 104 person-year (PY; 3.64:2.25:1) for CK-SBRT, 9.93 (7.32:2.33:1) for IMRT and 8.24 (15.99:2.35:1) for 3D-CRT (p ≤ 0.0002). We conclude that modern RT added more but small SCR from scatter/leakage and imaging doses. The primary field is a major contributor of risk which can be mitigated by the use of hypofractionation.

摘要

现代放射治疗(RT)采用改变分割、长照射时间和图像引导程序。本研究旨在比较前列腺治疗中使用调强放射治疗(IMRT)、CyberKnife 立体定向体部放射治疗(CK-SBRT)与三维适形放射治疗(3D-CRT)时,原发野、散射/漏射线和图像引导程序相关的继发癌症风险(SCR)。为 3D-CRT、IMRT(39 个 2Gy 分次)和 CK-SBRT(5 个 7.25Gy 分次)生成前列腺计划。使用 Schneider 的机械模型和器官当量剂量(OED)的概念计算原发野器官的超额绝对风险(EAR),以考虑剂量不均匀性。通过体模测量确定图像引导程序和散射/漏射线的剂量。结果表明,与常规分割相比,低分割会降低原发野器官的 SCR(p≤0.0001)。SCR 还受到剂量-体积分布的调节。对于场边缘附近的器官,如直肠和骨盆骨,CK-SBRT 计划由于高剂量区域无体积峰值,因此比 IMRT 和 3D-CRT 具有更好的风险特征(相对风险 [RR]:0.65、0.22,分别为 p≤0.0004)。CK-SBRT 和 IMRT 产生的散射/漏射线和成像剂量比 3D-CRT 多(p≤0.0002)。但原发野是 SCR 的主要贡献者。EAR 估计(风险贡献,原发野:散射/漏射线:成像程序)分别为 CK-SBRT 每 104 人年 7.1 例(3.64:2.25:1)、IMRT 每 104 人年 9.93 例(7.32:2.33:1)和 3D-CRT 每 104 人年 8.24 例(15.99:2.35:1)(p≤0.0002)。我们得出结论,现代 RT 增加了散射/漏射线和成像剂量的但较小的 SCR。原发野是风险的主要贡献者,可以通过采用低分割来减轻。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2eeb/8273793/c5ed3b00e3b8/rrab038f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2eeb/8273793/80cf82d38904/rrab038f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2eeb/8273793/c8406ce848c1/rrab038f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2eeb/8273793/c5ed3b00e3b8/rrab038f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2eeb/8273793/80cf82d38904/rrab038f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2eeb/8273793/c8406ce848c1/rrab038f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2eeb/8273793/c5ed3b00e3b8/rrab038f3.jpg

相似文献

1
Secondary cancer risk from modern external-beam radiotherapy of prostate cancer patients: Impact of fractionation and dose distribution.前列腺癌患者现代外照射放疗的继发癌症风险:分割和剂量分布的影响。
J Radiat Res. 2021 Jul 10;62(4):707-717. doi: 10.1093/jrr/rrab038.
2
Radiation-induced second primary cancer risks from modern external beam radiotherapy for early prostate cancer: impact of stereotactic ablative radiotherapy (SABR), volumetric modulated arc therapy (VMAT) and flattening filter free (FFF) radiotherapy.早期前列腺癌现代外照射放疗所致放射性第二原发癌风险:立体定向消融放疗(SABR)、容积调强弧形放疗(VMAT)及无均整器放疗(FFF)的影响
Phys Med Biol. 2015 Feb 7;60(3):1237-57. doi: 10.1088/0031-9155/60/3/1237. Epub 2015 Jan 15.
3
Constituent components of out-of-field scatter dose for 18-MV intensity modulated radiation therapy versus 3-dimensional conformal radiation therapy: a comparison with 6-MV and implications for carcinogenesis.18兆伏强度调制放射治疗与三维适形放射治疗的射野外散射剂量的组成成分:与6兆伏的比较及对致癌作用的影响
Int J Radiat Oncol Biol Phys. 2014 Nov 1;90(3):645-53. doi: 10.1016/j.ijrobp.2014.05.052. Epub 2014 Jul 30.
4
Persistently better treatment planning results of intensity-modulated (IMRT) over conformal radiotherapy (3D-CRT) in prostate cancer patients with significant variation of clinical target volume and/or organs-at-risk.在临床靶区体积和/或危及器官有显著差异的前列腺癌患者中,调强放疗(IMRT)的治疗计划结果始终优于适形放疗(3D-CRT)。
Radiother Oncol. 2008 Jul;88(1):77-87. doi: 10.1016/j.radonc.2007.12.011. Epub 2008 Jan 22.
5
Rectal dose sparing with a balloon catheter and ultrasound localization in conformal radiation therapy for prostate cancer.前列腺癌适形放射治疗中使用球囊导管和超声定位进行直肠剂量 sparing。(注:这里“sparing”可能是“ sparing”的拼写错误,推测意思是“ sparing”,有“减少、 sparing”之意,结合语境可理解为“直肠剂量减少”) 完整译文:前列腺癌适形放射治疗中使用球囊导管和超声定位减少直肠剂量
Radiother Oncol. 2003 Jun;67(3):285-94. doi: 10.1016/s0167-8140(03)00056-2.
6
Dose to bone marrow using IMRT techniques in prostate cancer patients.前列腺癌患者使用调强放射治疗技术时骨髓所接受的剂量。
Strahlenther Onkol. 2005 Mar;181(3):172-8. doi: 10.1007/s00066-005-1360-4.
7
Evaluation of geometrical uncertainties on localized prostate radiotherapy of patients with bilateral metallic hip prostheses using 3D-CRT, IMRT and VMAT: A planning study.使用 3D-CRT、IMRT 和 VMAT 评估双侧金属髋关节假体患者局部前列腺放疗的几何不确定性:一项计划研究。
J Xray Sci Technol. 2020;28(2):243-254. doi: 10.3233/XST-190598.
8
Pelvic nodal dose escalation with prostate hypofractionation using conformal avoidance defined (H-CAD) intensity modulated radiation therapy.使用适形避让定义的(H-CAD)调强放射治疗对前列腺低分割放疗时盆腔淋巴结剂量递增。
Acta Oncol. 2006;45(6):717-27. doi: 10.1080/02841860600781781.
9
Radiation-Induced Secondary Cancer Risk Assessment in Patients With Lung Cancer After Stereotactic Body Radiotherapy Using the CyberKnife M6 System With Lung-Optimized Treatment.使用带有肺部优化治疗功能的射波刀M6系统对肺癌患者进行立体定向体部放射治疗后辐射诱发的继发性癌症风险评估
Front Bioeng Biotechnol. 2020 May 7;8:306. doi: 10.3389/fbioe.2020.00306. eCollection 2020.
10
Prostate and seminal vesicle volume based consideration of prostate cancer patients for treatment with 3D-conformal or intensity-modulated radiation therapy.基于前列腺和精囊体积的考虑,为接受 3D-适形或调强放疗的前列腺癌患者进行治疗。
Med Phys. 2010 Jul;37(7):3791-801. doi: 10.1118/1.3451125.

引用本文的文献

1
The impact of fractionation on secondary malignancies in postoperative breast cancer irradiation.分次照射对乳腺癌术后放疗中继发恶性肿瘤的影响。
Breast. 2024 Dec;78:103819. doi: 10.1016/j.breast.2024.103819. Epub 2024 Oct 5.
2
Semi-experimental assessment of neutron equivalent dose and secondary cancer risk for off-field organs in glioma patients undergoing 18-MV radiotherapy.半实验评估 18MV 放疗中胶质瘤患者场外器官的中子当量剂量和二次癌症风险。
PLoS One. 2022 Jul 29;17(7):e0271028. doi: 10.1371/journal.pone.0271028. eCollection 2022.

本文引用的文献

1
Second malignancies after radiotherapy for prostate cancer: systematic review and meta-analysis.前列腺癌放疗后的第二原发性恶性肿瘤:系统评价与荟萃分析。
BMJ. 2016 Mar 2;352:i851. doi: 10.1136/bmj.i851.
2
Radiation-induced second primary cancer risks from modern external beam radiotherapy for early prostate cancer: impact of stereotactic ablative radiotherapy (SABR), volumetric modulated arc therapy (VMAT) and flattening filter free (FFF) radiotherapy.早期前列腺癌现代外照射放疗所致放射性第二原发癌风险:立体定向消融放疗(SABR)、容积调强弧形放疗(VMAT)及无均整器放疗(FFF)的影响
Phys Med Biol. 2015 Feb 7;60(3):1237-57. doi: 10.1088/0031-9155/60/3/1237. Epub 2015 Jan 15.
3
Minimizing second cancer risk following radiotherapy: current perspectives.
放疗后降低二次癌症风险:当前观点
Cancer Manag Res. 2014 Dec 17;7:1-11. doi: 10.2147/CMAR.S47220. eCollection 2015.
4
Assessment of uncertainties in radiation-induced cancer risk predictions at clinically relevant doses.临床相关剂量下辐射诱发癌症风险预测中不确定性的评估。
Med Phys. 2015 Jan;42(1):81-9. doi: 10.1118/1.4903272.
5
SBRT for the Primary Treatment of Localized Prostate Cancer: The Effect of Gleason Score, Dose and Heterogeneity of Intermediate Risk on Outcome Utilizing 2.2014 NCCN Risk Stratification Guidelines.SBRT 治疗局限性前列腺癌:利用 2014 年 NCCN 风险分层指南,基于格里森评分、剂量和中危肿瘤异质性对结局的影响。
Front Oncol. 2014 Nov 11;4:312. doi: 10.3389/fonc.2014.00312. eCollection 2014.
6
Progress and controversies: Radiation therapy for prostate cancer.进展与争议:前列腺癌的放射治疗。
CA Cancer J Clin. 2014 Nov-Dec;64(6):389-407. doi: 10.3322/caac.21250. Epub 2014 Sep 18.
7
The risk of radiation-induced second cancers in the high to medium dose region: a comparison between passive and scanned proton therapy, IMRT and VMAT for pediatric patients with brain tumors.高至中剂量区域辐射诱发二次癌症的风险:儿童脑肿瘤患者被动与扫描质子治疗、调强放射治疗和容积调强弧形治疗的比较
Phys Med Biol. 2014 Jun 21;59(12):2883-99. doi: 10.1088/0031-9155/59/12/2883. Epub 2014 May 15.
8
Stereotactic body radiation therapy and 3-dimensional conformal radiotherapy for stage I non-small cell lung cancer: A pooled analysis of biological equivalent dose and local control.立体定向体部放射治疗和三维适形放射治疗Ⅰ期非小细胞肺癌:生物等效剂量和局部控制的荟萃分析。
Pract Radiat Oncol. 2012 Oct-Dec;2(4):288-295. doi: 10.1016/j.prro.2011.10.004. Epub 2011 Dec 3.
9
Second primary cancers after radiation for prostate cancer: a systematic review of the clinical data and impact of treatment technique.前列腺癌放疗后的第二原发性癌症:临床数据及治疗技术影响的系统评价
Radiother Oncol. 2014 Feb;110(2):213-28. doi: 10.1016/j.radonc.2013.12.012. Epub 2014 Jan 30.
10
The tumor radiobiology of SRS and SBRT: are more than the 5 Rs involved?SRS 和 SBRT 的肿瘤放射生物学:涉及的不仅仅是 5 Rs 吗?
Int J Radiat Oncol Biol Phys. 2014 Feb 1;88(2):254-62. doi: 10.1016/j.ijrobp.2013.07.022.